CI
HRMY icon

CX Institutional’s Harmony Biosciences HRMY Stock Holding History

CX Institutional’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.45M Buy
259,496
+14,809
+6% +$467K 0.27% 82
2026
Q1 		$6.85M Sell
244,687
-31,122
-11% -$1.02M 0.21% 114
2025
Q4 		$10.3M Buy
275,809
+45,376
+20% +$1.49M 0.31% 75
2025
Q3 		$6.35M Buy
230,433
+22,650
+11% +$780K 0.19% 126
2025
Q2 		$6.57M Buy
207,783
+129,916
+167% +$4.18M 0.23% 100
2025
Q1 		$2.58M Buy
+77,867
New +$2.79M 0.1% 167

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CX Institutional's HRMY Position: Q2 2026 in Review

CX Institutional increased its Harmony Biosciences (HRMY) stake by 6.1% in Q2 2026, buying an estimated $467K and bringing the position to 259,496 shares worth $9.45M. The position accounts for 0.27% of the portfolio, ranked #82.

CX Institutional first reported a position in HRMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.3M in Q4 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • CX Institutional held 259,496 shares of Harmony Biosciences worth $9.45M as of Q2 2026.
  • CX Institutional bought 14,809 Harmony Biosciences shares in Q2 2026, an estimated $467K.
  • Harmony Biosciences made up 0.27% of CX Institutional's portfolio in Q2 2026, its #82 holding.
  • CX Institutional first reported a position in Harmony Biosciences in Q1 2025 and has held it in 6 quarters since.
  • CX Institutional's Harmony Biosciences position peaked at $10.3M in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.